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Abstract
Background:  Human papilloma virus (HPV) load and physical status are considered useful
parameters for clinical evaluation of cervical squamous cell neoplasia. However, the errors implicit
in HPV gene quantification by PCR are not well documented. We have undertaken the first
rigorous evaluation of the errors that can be expected when using SYBR green qPCR for
quantification of HPV type 16 gene copy numbers. We assessed a modified method, in which
external calibration curves were generated from a single construct containing HPV16 E2, HPV16
E6 and the host gene hydroxymethylbilane synthase in a 1:1:1 ratio.
Results: When testing dilutions of mixed HPV/host DNA in replicate runs, we observed errors in
quantifying E2 and E6 amplicons of 5–40%, with greatest error at the lowest DNA template
concentration (3 ng/μl). Errors in determining viral copy numbers per diploid genome were 13–
53%. Nevertheless, in cervical keratinocyte cell lines we observed reasonable agreement between
viral loads determined by qPCR and Southern blotting. The mean E2/E6 ratio in episome-only cells
was 1.04, but with a range of 0.76–1.32. In three integrant-only lines the mean E2/E6 ratios were
0.20, 0.72 and 2.61 (values confirmed by gene-specific Southern blotting). When E2/E6 ratios in
fourteen HPV16-positive cervical carcinomas were analysed, conclusions regarding viral physical
state could only be made in three cases, where the E2/E6 ratio was ≤ 0.06.
Conclusion: Run-to-run variation in SYBR green qPCR produces unavoidable inaccuracies that
should be allowed for when quantifying HPV gene copy number. While E6 copy numbers can be
considered to provide a useable indication of viral loads, the E2/E6 ratio is of limited value. Previous
studies may have overestimated the frequency of mixed episomal/integrant HPV infections.
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Background
Cervical carcinoma is the second most common malig-
nancy affecting women [1]. Most cases are squamous cell
carcinomas (SCCs), which develop from precursor squa-
mous intraepithelial lesions (SILs). At present it is not
possible to discriminate progressive from non progressive
SIL, leading to over-treatment of large numbers of
women, with attendant physical and psychological mor-
bidity.
Persistent infection by high risk human papillomavirus
(HR-HPV) represents the most significant risk factor in
development of cervical carcinoma [2,3], with HPV16
being the virus type most commonly seen in SCC. In cer-
vical malignancy HPV is usually integrated into the host
genome. Integration is characterised by retention of the
viral oncogenes E6 and E7, and by disruption or loss of
expression of the viral transcriptional repressor E2, lead-
ing to deregulated production of E6 and E7 [4].
Various PCR based assays have been devised to measure
HPV copy number and physical state in cell lines and clin-
ical samples [5-13], with a view to deriving clinically or
biologically useful information. Viral load is often deter-
mined from levels of genes present in episomes and inte-
grants (i.e. E6 or E7), while physical state is inferred from
the E2/E6 (or E2/E7) ratio. The latter approach is based on
the notion that episome only infections would harbour
an equivalent copy number of E2 and E6, giving an E2/E6
ratio of 1, while integrated virus with loss of E2 would give
an E2/E6 ratio of 0, and a mixed episomal and integrant
infections would give ratios between 0 and 1.
Both TaqMan and SYBR green strategies have been devel-
oped for HPV gene PCR, with the latter approach offering
advantages of simplicity and low cost. Existing methods
adjust for sample cellularity, generally determining HPV
gene copy numbers per unit mass of genomic DNA
(gDNA), per copy of an independent host calibrator gene,
or with reference to a cell line [5-8,11-14]. These
approaches are potentially liable to error, for example
through inaccuracies in DNA concentration measure-
ment, or from errors in handling and pipetting template
DNAs for the construction of separate calibration curves.
Small inaccuracies in quantification or dispensing of tem-
plate DNA can translate to large over- or under-estimates
of viral content, on account of the large dynamic range
and sensitivity of real time PCR.
Despite these concerns, and the potential use of quantita-
tive PCR (qPCR) data in clinical decision-making, remark-
ably few previous studies have undertaken detailed
technical evaluation of the performance of PCR methods
for assessing HPV load and physical state. The existing
reports have typically been carried out using DNA mix-
tures or cell lines, but not both, and have only rarely been
performed to a good standard [10,11]. Where quantitative
data is available it generally suggests substantial inaccu-
racy. One study showed a ten fold difference in the abso-
lute values for HPV quantification between two
laboratories (attributable to differences in the calibration
standards used) [10], while another determined a viral
load in the cervical SCC cell line SiHa of 37 copies per cell
[13], which is far in excess of the approximately three cop-
ies actually present [15,16].
As the literature contains no adequate evaluation of the
errors inherent in SYBR green qPCR analysis of HPV gene
copy number, the present study sought to rectify this
omission. We undertook detailed assessment of a modi-
fied SYBR green based qPCR strategy for absolute quanti-
fication of the copy number of HPV16 E2 and E6 genes,
compared to a host diploid genome. We produced a single
clone, NA6, containing the amplicons HPV16 E2, HPV16
E6 and host gene hydroxymethylbilane synthase (HMBS;
located at 11q23.3) in a 1:1:1 ratio, for use in generating
external calibration curves. In principle, this system may
offer advantages of simplicity and comparability. Firstly,
all external calibration curves are generated from one tem-
plate dilution series, rather than several series required
with independent calibration constructs (for example,
three would be required for measurement of E2, E6 and
HMBS), thereby reducing the amount of manual handling
needed. Secondly, the amount of host gDNA in each test
sample can be quantified directly with reference to the
HMBS standard curve, rather than relying on an estima-
tion of gDNA concentration by spectrophotometry.
Thirdly, a standardised calibration construct such as NA6
may reduce inter-laboratory variation in HPV gene quan-
tification.
We have undertaken rigorous evaluation of the perform-
ance of HPV16 SYBR green qPCR and present data docu-
menting the potential sources of error, even in the 'best
case scenario' of cell line analysis. We first used mixtures
of HPV16 DNA and host gDNA, then cervical keratinocyte
cell lines in which the HPV16 copy number and physical
state were determined by Southern blot and densitometry,
and finally HPV16-positive SCC tissue samples. We dem-
onstrate the error range that should be anticipated when
quantifying HR-HPV gene copy number by SYBR green
qPCR. We also show that E2/E6 ratios are of limited use in
assessing HR-HPV physical state, being of value only for
identifying the subset of integrant-containing cells in
which the E2/E6 ratio is near zero.
Methods
Cell lines
The HPV16 positive cervical SCC cell lines SiHa, and
CaSki and the HPV negative cervical SCC line C33A (all atBMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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high passage) were obtained from the American Type Cul-
ture Collection (ATCC). We also used early and late pas-
sages from one long-term culture series of the W12 cell
line (W12 Series1; W12.Ser1). W12 was established from
a cervical low grade SIL and in long term culture recapitu-
lates cervical neoplastic progression genetically and phe-
notypically [17-20]. All cell lines were propagated in
monolayer culture, as described previously [18,21] or by
the ATCC.
Genomic DNA extraction
Genomic DNA (gDNA) was prepared from pelleted cells
by overnight digestion with proteinase K, brief phenol
chloroform extraction, ethanol precipitation, and
removal of contaminating RNA by RNAse A. The purified
gDNA was quantified by spectrophotometry.
Cloning of E2, E6 and HMBS amplicons into NA6
E2, E6 and HMBS amplicons were cloned separately, fol-
lowing PCR amplification, into pcr®2.1 vector using the
original TA cloning system (Invitrogen). Briefly, frag-
ments of the E2 hinge region (81 bp), and E6 gene (80 bp)
were amplified from the pSP64-HPV16 construct (which
contains the 7.9 kb full length HPV16 genome [20]),
while a section of HMBS (118 bp) was amplified from
peripheral blood lymphocyte gDNA. PCR was carried out
on an Applied Biosystems 9700 using the AmpliTaq Gold
system (Perkin Elmer, UK) and comprised 1 × Taq Buffer,
1.5 mM MgCl2, 200 μM dNTPs, 300 μM Primer Pairs, and
2 U of Taq polymerase. PCR primers and cycling condi-
tions are listed in Table 1.
In order to construct a single clone containing each ampli-
con in a 1:1:1 ratio, the following cloning strategy was
adopted. The E2 and E6 clones were linearised with XbaI,
and the products ligated with T4 DNA ligase. Using the
ligated product as template, PCR with E2 forward and E6
reverse primers generated a single E2-E6 product for sub-
sequent TA cloning. Following selection, a single E2-E6
clone and a separate HMBS clone were digested with Hin-
dIII, and similarly ligated together. PCR with E2 forward
and HMBS reverse primers generated a single product that
following TA cloning, selection and sequencing, was
shown to contain a single copy of the E2, E6 and HMBS
amplicons (Figure 1). The final clone, named NA6, is
4,382 bp and has a molecular weight of 2.892 × 106 Da.
Preparation of NA6 calibration curves
Stock NA6 was prepared at a concentration of 100 μg/ml.
Ten fold serial dilutions were undertaken to produce a
titration series representing, 1 ng/μl, 100 pg/μl, 10 pg/μl,
1 pg/μl, 100 fg/μl, 10 fg/μl and 1 fg/μl of NA6. From this,
calibration curves for E2, E6 and HMBS were produced in
quadruplicate. For each of the four qPCR runs, each dilu-
tion point was assayed in triplicate. qPCR was undertaken
using 2 μl of template DNA in a 25 μl PCR. For the most
concentrated point within the dilution series (1 ng/μl), 2
ng of NA6 equates to 4.176 × 108 copies of each amplicon.
For the most dilute point, 2 fg equates to 4.176 × 102 cop-
ies. Additional file 1, 'NA6 Standard Curves' worksheet,
presents the raw data used in calibration curve construc-
tion.
SYBR Green qPCR
All qPCR was carried out using an Opticon I thermal
cycler (MJ Research) with SYBR Green JumpStart qPCR
Kits (Sigma, UK). Reactions comprised 1× SYBR Green
mix, 500 nM primer pairs, and 2 μl of template. In initial
optimisation experiments we investigated the effects of
primer concentration on crossing point (Cp) determina-
tion. We found that a primer concentration of 500 nM
was optimal, and that a reduction to 300 nM resulted in
PCR artefacts at low template concentrations. It was found
that a template volume of 2 μl could be dispensed more
accurately and reproducibly than 1 μl volumes (data not
shown).
The following cycling conditions were employed: initial
denaturation 94°C 2 min, followed by 40 cycles of 94°C
20 seconds, 58°C 20 seconds, 72°C 20 seconds, 76°C 15
seconds, plate read. A final extension of 72°C 10 minutes,
and melting curve of 65°C to 90°C, 1°C/second transi-
tion were incorporated. Opticon raw data was exported to
Microsoft Excel for analysis.
Data analysis
Absolute quantification strategies require that the fluores-
cence threshold used to derive the calibration curve is also
Table 1: Primers used to generate NA6 and for qPCR.
Primers Sequence (5' to 3') Product length (bp) Reference
E2 F AAC GAA GTA TCC TCT CCT GAA ATT ATT AG 81 [13]
E2 R CCA AGG CGA CGG CTT TG
E6 F GAG AAC TGC AAT GTT TCA GGA CC 80 [13]
E6 R TGT ATA GTT GTT TGC AGC TCT GTG C
HMBS F GCC TGC AGT TTG AAA TCA GTG 118 [32]
HMBS R CGG GAC GGG CTT TAG CTA
F refers to forward primers and R to reverse primers.BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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applied to the sample data. Hence it may be anticipated
that little effect would be experienced by varying the fluo-
rescence threshold (Ft), provided that the Ft passes
through the centre of the log transformed reaction curve
data. However, we found that gross changes in absolute
quantification were seen for relatively small changes in Ft
following theoretical evaluations (data not shown). To
avoid issues related to placement of Ft values, an auto-
mated derivation of optimum Ft assignment was imple-
mented. Fluorescence thresholds were calculated for each
of the four calibration curves according to the cycle before
second derivative maxima method, and then averaged
during the process of producing the calibration curve. The
E2, E6 and HMBS Ft values were then applied to all sam-
ple data in order to calculate crossing points.
Calibration curves for E2, E6 and HMBS were constructed
by plotting crossing points (Cp) versus the log of template
copy number. For copy number determination in test
samples, the fluorescence threshold (Ft), primer efficiency
(E) and numbers of molecules at fluorescence threshold
(Nt) were taken to be constants and were determined as
the means of the four standard curve replicates for each
amplicon. Hence, for an unknown sample, number of
copies is given by equation 1.
Calibration curve primer efficiencies were determined by
equation 2, and numbers of molecules at threshold by
equation 3.
Copies
Nt
E
=
+ () 1 Cp (1)
E =
− ⎡
⎣
⎢
⎢
⎢
⎢
⎤
⎦
⎥
⎥
⎥
⎥
− 10
1
1 slope (2)
Sequence of NA6 clone insert demonstrates that E2, E6 and HMBS amplicons are present in equimolar amounts Figure 1
Sequence of NA6 clone insert demonstrates that E2, E6 and HMBS amplicons are present in equimolar 
amounts. The M13 forward primer of pcr2.1 TA vector is shown at 195 bp in bold, underlined. E2, E6 and HMBS amplicons 
are shown in bold italics, with primer binding sites underlined. The M13 reverse primer is at 850 bp, bold and underlined.
       1  ………………………… CACCACACCC GCCGCGCTAA ATGCGCCGCT ACAGGGGCGC 
      51  GTCCATTCGC CATTCAGGCT GCGCAACTGT TGGGAAGGGC GATCGGTGCG 
     101  GGCCTCTTCG CTATTRCSCM RGCTGGCGAA AGGGGGGATG TGCTGCAAGG 
M13Fwd (195-211) 
     151  CGATTAAGTT GGGGTAACGC CAGGGTTTTC CCCAGTCACG ACGTTGTAAA
     201  ACGACGGCCA GTGAATTGTA ATACGACTCA CTATAGGGCG AATTGGGCCC 
     251  TCTAGATGCA TGCTCGAGCG GCCGCCAGTG TGATGGATAT CTGCAGAATT 
E2 (307-388, 81 bp) 
     301  CGGCTTAACG AAGTATCCTC TCCTGAAATT ATTAGGCAGC ACTTGGCCAA
     351  CCACTCCGCC GCGACCCATA CCAAAGCCGT CGCCTTGGAA GCCGAATTCC 
     401  GGCACACTGG CGGCCGTTAC TAGATGCATG CTCGAGCGGC CGCCAGTGTG 
E6 (555-475, 80 bp) 
     451  ATGGATATCT GCAGAATTCG GCTTTGTATA GTTGTTTGCA GCTCTGTGCA
     501  TAACTGTGGT AACTTTCTGG GTCGCTCCTG TGGGTCCTGA AACATTGCAG
     551  TTCTCAAGCC GAATTCCAGC ACACTGGCGG CCGTTACTAG ATGCATGCTC 
HMBS (642-760, 118 bp) 
     601  GAGCGGCCGC CAGTGTGATG GATATCTGCA GAATTCGGCT TGCCTGCAGT
     651  TTGAAATCAG TGAGTTTTCT GGAAAGGAGT GGAAGCTAAT GGGAAGCCCA
     701  GTACCCCGAG AGGAGAGAAC ACAACATTTC TGGCTTTGCC TATAGCTAAA
     751  GCCCGTCCCG AAGCCGAATT CCAGCACACT GGCGGCCGTT ACTAGTGGAT 
M13Rev (850-831) 
     801  CCGAGCTCGG TACCAAGCTT GGCGTAATCA TGGTCATAGC TGTTTCCTGT
     851  GTGAAATTGT TATCCGCTCA CAATTCCACA CAACATACGA GCCGGAAGCA 
     901  TAAAGTGGTA AAGCCTGGGG GTGCCTAAAT GAGTGAGCTA ACTCACAWTT 
951  AATTGCGTTG CGCTCACTGC ………………………… BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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Nt = 10intercept (3)
The coefficient of variation between data obtained in rep-
licate calibration curves represented the ratios of standard
deviations over the mean, multiplied by 100%.
Gene copy numbers in test samples were obtained by
comparing the Cp value to those in the relevant external
calibration curve. A Microsoft Excel template was pre-
pared to calculate viral loads, and E2/E6 ratios (see Addi-
tional file 1). For all samples, viral load per diploid
genome was determined by dividing E2 and E6 copy num-
bers by half the HMBS copy number. In addition, for the
cell lines, the viral load per cell was derived using the
known ploidy status.
Southern hybridisation
In order to validate the qPCR method, comparisons were
made with HPV16 copy numbers determined in cervical
keratinocyte cell lines by Southern blotting. 5 μg of gDNA
was digested at 37°C overnight with either BamH1, PstI or
HindIII, and electrophoresed on a 0.8% agarose gel. Aga-
rose gels were depurinated in 0.25 M HCl, denatured in
0.5 M NaOH/1.5 M NaCl and neutralised in 0.5 M tris
HCl/3 M NaCl before transfer to Hybond N membrane.
UV cross-linked membranes were prehybridised in 20 ml
of hybridisation buffer for 4 hrs at 65°C prior to introduc-
tion of 32P-dCTP labelled probe. Probes were generated
from the previously described E2 and E6 amplicons (81
and 80 bp respectively) cloned into pcr2.1 TA cloning vec-
tor, or from full length HPV16 (7.9 kbp) excised from
pSP64-HPV16 using BamH1, and labelled using
RediPrime labelling kit. Hybridisation was for 16 hr, fol-
lowed by stringency washing of membranes in 2 × SSC/
0.1% SDS and 0.1 × SSC/0.1% SDS twice for 15 minutes,
and then autoradiography.
Clinical samples
Cervical squamous cell carcinoma samples were kindly
provided by Dr Geetashree Mukherjee from the archives
of the Kidwai Memorial Institute of Oncology, Bangalore,
India. All tissue samples were obtained with informed
consent, anonymised, and used with approval from the
Kidwai Local Research Ethics Committee (reference: PER/
CAB-I/D-I/13/01).
gDNA was prepared from 14 snap frozen HPV16-positive
cervical SCC samples, as described elsewhere [21]. The
mean total yields were insufficient for Southern blotting
to be performed to provide comparative data (data not
shown). Additional file 1, 'Assessment of Clinical Sam-
ples' worksheet, presents the raw data from the qPCR
analysis of the clinical sample viral load and E2/E6 ratios.
Results
Validation of NA6 standard curves using mixtures of virus 
and host DNA
In generating the NA6 construct and preparing the calibra-
tion curves (see Materials and Methods), PCR primers
were chosen to give amplicons of similar length (Table 1).
The E2 primers, amplifying bp 3,361–3,442 of the HPV16
genome (GenBank accession AF125673), were located in
the part of the E2 open reading frame (ORF) that is most
often deleted on HPV16 integration [5]. The E6 primers
were located in the E6 ORF (bp 94–174), while the HMBS
primers spanned an exon-intron border. After cloning, the
1:1:1 relationship of the E2, E6 and HMBS amplicons in
NA6 were confirmed by sequence analysis (Figure 1).
The SYBR green qPCR method used was developed fol-
lowing numerous optimisation experiments to determine
ideal primer concentration, template gDNA concentration
and cycling parameters (see Materials and Methods). We
analysed melting curves of reaction products to verify spe-
cificity of primer binding and thereby circumvent any
issues of non-specific SYBR green fluorescence. Following
four replicate qPCR runs, seven point external calibration
curves were generated for E2, E6 and HMBS. Figure 2A –
C shows representative qPCR data used to generate stand-
ard curves for E2 (Fig 2A; from replicate 1 of 4), E6 (Fig
2B; from replicate 2 of 4), and HMBS (Fig 2C; from repli-
cate 3 of 4). Quantification of each gene was linear over
six logs, with no evidence to suggest competition between
the PCR targets in the NA6 construct.
Tight correlations were observed between the values
obtained for each amplicon in the replicate qPCR runs, as
illustrated for the E2 amplicon in Figure 2D (R2 = 0.996).
For each amplicon, the mean Cp for each titration point 1
ng/μl to 1 fg/μl was plotted to generate the final calibra-
tion curves, which are shown in Figure 2E, together with
their respective line equations and correlation values.
Despite the apparent concordance between replicate runs,
when we calculated viral gene copy number using calibra-
tion curves generated from individual qPCR runs, we
observed inter-assay differences in the copy number val-
ues generated. Each of the four replicate calibration curves
(Replicate 1 to Replicate 4) for E2, E6 and HMBS ampli-
cons, as well as the final mean calibration curve derived
from the quadruplicate runs, were used to calculate gene
copy number according to a series of theoretical crossing
points (Cp; the cycle number where the fluorescence
threshold was crossed), ranging from a Cp of 10 to 30
(Table 2). The inter-run coefficients of variation in quan-
tification of gene copy number at each crossing point
ranged from approximately 4% to 31% (see penultimate
row of each section of Table 2), which is in agreementBMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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with previously published findings [5,10,11]. There was
no apparent trend according to crossing point, with as
much variation at low Cp values as at high Cp values
(Table 2), indicating that, in contrast to other methods
[10,11], template concentration did not affect inter-assay
variation. Nevertheless, this data indicates that there is
unavoidable run to run variation in HPV qPCR, reflecting
for example, the consequences of repeated manual han-
dling in replicate runs. We therefore suggest that the gen-
eration of a reliable standard curve for HPV gene
quantification requires averaging of replicate calibration
runs, rather than depending on a single run.
We next assessed the ability of our absolute qPCR strategy
accurately to quantify viral E2 and E6 copy number at a
broad range of concentrations within a background of
human DNA. The raw data from this work is presented in
Additional file 1 'Accuracy Test' worksheet. Test DNA
stock was generated by mixing 50 ng of human gDNA
with 10 pg of the plasmid pSP64-HPV16 (which contains
Generation of mean NA6 calibration curve for E2, E6 amd HMBS quantification Figure 2
Generation of mean NA6 calibration curve for E2, E6 amd HMBS quantification. Panels A – C show representative 
data from the four replicate PCR runs using serially diluted NA6 as template (2 ng – 2 fg), from which the mean calibration 
curve for viral quantification was generated. The different curves correspond to different starting amounts of template. The flu-
orescence thresholds are indicated by the lines of crosses running horizontally. Panel A shows E2 log transformed data from 
replicate 1 qPCR run, panel B shows HMBS log transformed data from replicate 3 qPCR run, panel C shows E6 log trans-
formed data from replicate 2 qPCR run. Panel D demonstrates the tight correlation between the data points generated for the 
E2 amplicon at each template concentration in the four replicate runs. Similar findings were made for the E6 and HMBS ampli-
cons. Panel E shows the mean calibration curves for E2, E6 and HMBS used for viral gene copy number quantification, together 
with the respective line equations.
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Table 2: Effect of standard curve selection on E6, E2 and HMBS gene copy number calculations.
E6 Correlation 
Coefficient 
(R2)
Primer 
Efficiency 
(E)
Number of 
molecules at 
threshold 
(Nt)
E6 gene copy numbers over a range of theoretical crossing points
10 15 20 25 30
Final 
calibration 
curve for E6
0.9963 95.01% 3.3806E+11 4.25E+08 1.51E+07 5.34E+05 1.89E+04 6.72E+02
Replicate 1 0.9988 87.79% 1.43162E+11 2.62E+08 1.12E+07 4.81E+05 2.06E+04 8.82E+02
Replicate 2 0.9909 101.86% 5.85431E+11 5.21E+08 1.56E+07 4.64E+05 1.39E+04 4.13E+02
Replicate 3 0.9982 96.56% 3.68007E+11 4.28E+08 1.46E+07 4.97E+05 1.69E+04 5.77E+02
Replicate 4 0.9973 93.84% 2.55641E+11 3.41E+08 1.25E+07 4.56E+05 1.67E+04 6.09E+02
Coefficient of 
variation of 
replicates
28.72% 14.58% 3.83% 16.27% 31.32%
Mean copy 
number of 
replicates
3.88E+08 1.35E+07 4.74E+05 1.70E+04 6.20E+02
E2 Correlation 
Coefficient 
(R2)
Primer 
Efficiency 
(E)
Number of 
molecules at 
threshold 
(Nt)
E2 gene copy numbers over a range of theoretical crossing points
10 15 20 25 30
Final 
calibration 
curve for E2
0.9945 90.86% 2.42762E+11 3.79E+08 1.49E+07 5.90E+05 2.33E+04 9.02E+02
Replicate 1 0.9887 88.55% 1.92376E+11 3.39E+08 1.42E+07 5.96E+05 2.50E+04 0.9887
Replicate 2 0.9945 93.10% 2.8539E+11 3.96E+08 1.48E+07 5.49E+05 2.05E+04 0.9945
Replicate 3 0.9973 92.70% 3.11657E+11 4.41E+08 1.66E+07 6.25E+05 2.35E+04 0.9973
Replicate 4 0.9976 89.07% 1.81623E+11 3.11E+08 1.29E+07 5.33E+05 2.21E+04 0.9976
Coefficient of 
variation of 
replicates
15.69% 10.60% 7.36% 8.57% 13.06%
Mean copy 
number of 
replicates
3.72E+08 1.46E+07 5.76E+05 2.28E+04 9.02E+02
HMBS Correlation 
Coefficient 
(R2)
Primer 
Efficiency 
(E)
Number of 
molecules at 
threshold 
(Nt)
HMBS gene copy numbers over a range of theoretical crossing 
points
10 15 20 25 30
Final 
calibration 
curve for 
HMBS
0.9970 91.05% 2.28115E+11 3.52E+08 1.38E+07 5.44E+05 2.14E+04 8.40E+02
Replicate 1 0.9951 89.10% 1.333E+11 2.28E+08 9.43E+06 3.90E+05 1.61E+04 6.67E+02
Replicate 2 0.9985 95.39% 3.52583E+11 4.35E+08 1.53E+07 5.36E+05 1.88E+04 6.60E+02
Replicate 3 0.9990 90.43% 2.4809E+11 3.96E+08 1.58E+07 6.31E+05 2.52E+04 1.01E+03
Replicate 4 0.9953 89.26% 1.78485E+11 3.03E+08 1.25E+07 5.13E+05 2.11E+04 8.71E+02BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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full-length HPV16 [20]) per microliter. The mixture was
then used to produce a three point serial dilution (Table
3). The starting population theoretically represented
760,000 E2 and E6 amplicons, and 28,571 HMBS ampli-
cons per 2 μl of NA6 template (the volume of template
loaded in each PCR reaction), which equated to a load of
53 HPV16 copies per diploid genome.
DNA concentrations of each titration point were deter-
mined by spectrophotometry, measuring each sample
three times. The mean values so determined were 51 ng/
μl, 11 ng/μl and 3 ng/μl (Table 3) and these were used to
calculate the anticipated amounts of the amplicons of E2,
E6 and HMBS in the 2 μl of template assayed, for compar-
ison with the values determined by qPCR.
Table 3 shows the mean data for each test sample
(obtained from three replicate qPCR runs), compared
with the predicted amounts of amplicon. Moderate varia-
tion (17.5–39.7% for E2 and 5.2–18.9% for E6) was seen
at each concentration point; with greatest overall error at
the lowest test sample concentration (3 ng/μl of gDNA;
representing about 1,600 diploid cells per 2 μl of sample),
where the limits of accuracy of qPCR at low template con-
centrations had presumably been exceeded.
When we determined viral gene copy number per diploid
genome, we obtained figures of approximately 25 E6 cop-
ies per diploid genome in the 51 ng/μl sample; 46 E6 cop-
ies per diploid genome in the 11 ng/μl sample; and 78 E6
copies per diploid genome in the 3 ng/μl sample, com-
pared to the anticipated 53 copies per diploid genome
(Table 3). These figures represent errors of 53%, 13%, and
47% respectively. The error is not surprising given the run
to run variation we observed in the qPCR optimisation
reactions, plus the fact that the experiments we performed
required serial dilution of test samples and measurement
of DNA concentrations by spectrophotometry, of which
represent potential sources of error. This error in absolute
quantification of HPV gene copy number by qPCR should
be anticipated in future studies.
Coefficient of 
variation of 
replicates
27.36% 22.14% 19.17% 18.93% 20.99%
Mean copy 
number of 
replicates
3.40E+08 1.32E+07 5.18E+05 2.03E+04 8.01E+02
In the main part of each section the rows represent the values for the final calibration curve and for the four replicate qPCR runs of the 7 point 
NA6 titration series, from which the final curve was generated. The right-hand five columns give the gene copy numbers determined from each 
curve at theoretical crossing points ranging from 10 to 30. In the bottom part of each section the numbers represent the coefficient of variation in 
mean copy number determined between the four replicate qPCR runs, together with the mean copy number determined from replicates 1 – 4 at 
each Cp.
Table 2: Effect of standard curve selection on E6, E2 and HMBS gene copy number calculations. (Continued)
Table 3: Dynamic range of E2, E6 and HMBS quantification by qPCR.
Template 
DNA per 
μl
Expected quantification in 2 μl Observed quantification with percent change over expected
E2 E6 HMBS E2/
E6
E6 per 
diploid 
genome
E2 E6 HMBS E2/
E6
E6 per 
diploid 
genome
51 ng 
gDNA 10 
pg pSP64 
HPV16
760,000 760,000 28,571 1 53 893,063 +17.5% 616,115 -18.9% 49,816 +74.4% 1.4 25
11 ng 
gDNA 2.16 
pg pSP64 
HPV16
163,922 163,922 6,163 1 53 208,404 +27.1% 172,423 +5.2% 7,437 +20.7% 1.2 46
3 ng gDNA 
60 fg pSP64 
HPV16
44,665 44,665 1,679 1 53 26,956 -39.7% 40,597 -9.1% 1,047 +37.6% 0.7 78
Peripheral blood lymphocyte gDNA was spiked with a known quantity of HPV16 DNA (in the pSP64-HPV16 plasmid). The template DNA was 
serially diluted, and absolute amounts were measured by spectrophotometry. The template DNA values are given in the first column of the Table. 
The anticipated gene copy numbers for E2, E6 and HMBS were derived, and are shown in the 'Expected quantification' section. qPCR of the serially 
diluted samples was performed, and the observed gene copy numbers are reported in the 'Observed quantification' section.BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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Estimation of viral load and physical status in HPV16 
infected cell lines
We next assessed the performance of NA6-based absolute
SYBR green qPCR in cervical keratinocyte cell lines in
which the copy number and physical state of HPV16 were
determined using Southern blotting and densitometry.
Raw data from this assessment is presented in Additional
file 1 'Assessment of Cell Lines' worksheet.
We undertook Southern hybridisation of BamH1 and
HindIII digested gDNA from the cell lines C33A,
W12.Ser1p16, W12.Ser1p57, CaSki, and SiHa (Figure 3,
panels A-C). We used three different probes: full length
HPV16 (7.9 Kbp), and the previously cloned E2 and E6
amplicons (81 and 80 bp respectively). For each probe,
target sequence load was determined by autoradiographic
comparison with copy number controls generated from
full length HPV16, excised from the pSP64-HPV16 con-
struct, and used at a range of 500 to 1 copy per 5 μg of host
gDNA (right-hand lanes in Figure 3A). Viral loads were
determined per cell, taking ploidy into account. The data
was compared with viral loads determined by qPCR
assessment of HPV16 E2 or E6 amplicon copies per dip-
loid genome (Table 4). The HPV negative cervical SCC cell
line C33A showed no signal by Southern blot and the
Southern analysis of HPV16 copy number and physical state in the cervical keratinocyte cell lines used to validate the NA6  qPCR method Figure 3
Southern analysis of HPV16 copy number and physical state in the cervical keratinocyte cell lines used to vali-
date the NA6 qPCR method. The three panels represent blots probed with full length HPV16 (A), the HPV16 E2 amplicon 
(B) and the HPV16 E6 amplicon (C). The lanes marked B are BamH1 digests, while the lanes marked H are Hind III digests. The 
right hand lanes in Panel A show copy number controls for estimates of viral load, ranging from 500 to 1 copies of full length 
HPV16 per 5 μg of normal peripheral blood lymphocyte gDNA. C33A is HPV16 negative, CaSki contains integrated HPV16 at 
high copy, SiHa contains integrated HPV16 at low copy, W12.Ser1p16 contains episomal HPV16, and W12.Ser1p57 contains a 
single HPV16 integrant (arrowed). The inset at the bottom of Panel A shows the faint signal produced by the HPV16 integrant 
in W12.Ser1p57 following prolonged (72 hr) exposure. For CaSki cells, the signal produced with the E2 probe (Panel B) is con-
siderably greater than that with the E6 probe (Panel C) and additional E2 bands are present (boxed in Panel B), indicative of 
multiple integration sites.
C33A CaSki SiHa W12
p16
W12
p57
BHBHBHBHBH
5
0
0
1
0
0
5
0
1
0
5
1
C33A CaSki SiHa W12
p16
W12
p57
BH BH BH BH BH
C33A CaSki SiHa W12
p16
W12
p57
BH BH BH BH BH
Full Length HPV16 Probe E2 Amplicon Probe E6 Amplicon Probe
Additional E2 bands (boxed)  in CaSki
A. B. C.BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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viral gene copy number values determined by qPCR were
also zero.
Using full length HPV16 as probe, W12.Ser1p16 (known
to be diploid [18]) was found to contain approximately
100 HPV16 episomes per cell, with no detectable inte-
grants. qPCR indicated 143 E6 copies per diploid genome
and 148 E2 copies per diploid genome. This represented a
viral load of 143 copies per cell. The mean E2/E6 ratio
determined from the absolute qPCR data was 1.04, as
would be predicted in cells containing episomes only,
although the range in triplicate qPCR runs was 0.76 to
1.32.
By Southern blotting using full length HPV16,
W12.Ser1p57 (known to be near tetraploid [18]) was epi-
some free and only a faint signal indicative of a single viral
integrant was seen after 72 hrs exposure (Figure 3A). There
were no detectable signals using the E2 or E6 amplicons as
probe, even after 8 days of exposure, reflecting the predict-
ably limited sensitivity of Southern blotting using 80 or
81 bp probes. By qPCR we observed a relatively wide
range of copy number values in W12.Ser1p57, consistent
with increased error at low sample concentrations (see
Table 3). The mean copy number values determined from
the absolute quantification data were 0.2 E2 copies and
0.3 E6 copies per diploid genome, indicating a viral load
Table 4: Comparison of HPV16 viral load and physical state determined by Southern hybridisation with NA6 qPCR analysis of HPV16 
E2 and E6 copy numbers in cervical keratinocyte cell lines.
Cell line Ploidy Southern analysis 
Copy numbers 
per cell
NA6 qPCR analysis
E2 copies per 
diploid genome
E6 copies per 
diploid genome
Viral load per cell Ratio of E2/E6 
(range)
C33A Near triploid HPV16 negative 0 0 0 0.00
W12.Ser1p16 Diploid Episomal 
(approx 100 copies)
148 143 143 1.04 (0.76–1.32)
W12.Ser1p57 Tetraploid Integrated 
(approx 1 copy)
0.2 0.3 1 0.72 (0.57–3.82)
SiHa Triploid Integrated 
(2–3 copies)
0.7 3.4 5 0.20 (0.11–0.24)
CaSki Tetraploid Integrated 
(>1000 copies)
2,272 869 1,738 2.61 (1.37–3.46)
Values less than 1 were rounded to the nearest whole number when calculating viral load per cell. E2/E6 ratio values were calculated from the 
qPCR readings for E2 and E6 and rounded to the nearest two decimal places.
Table 5: NA6 qPCR analysis of E2 and E6 copy numbers in cervical SCC samples.
Cervical SCC sample ID E2 copies E6 copies Viral load level Ratio of E2/E6
G30 2 1 Low 1.28
G1 0 2 Low 0.21
G31 04 L o w 0 . 0 6 *
n55 05 L o w 0 . 0 1 *
G19 12 10 Low 1.26
G12 35 35 Low 0.99
n12 44 42 Low 1.03
n10 73 48 Low 1.54
G26 461 297 Medium 1.55
G18 258 343 Medium 0.75
G6 467 423 Medium 1.10
G3 384 528 Medium 0.73
G9 0 691 Medium 0.00*
G11 954 2,481 High 0.38
HPV gene copy numbers are per diploid genome. E2/E6 ratio values were calculated from the qPCR readings for E2 and E6 and rounded to the 
nearest two decimal places. The only samples in which HPV16 physical state could be inferred with confidence are marked by asterisks in the right 
hand column.BMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
Page 11 of 14
(page number not for citation purposes)
of approximately one copy per tetraploid cell (after
rounding up). The mean E2/E6 ratio determined from the
qPCR data was 0.72, with a range of 0.57 to 3.82. The
presence of amplifiable E2 in W12.Ser1p57 is not surpris-
ing, as we previously determined retention of the hinge
region in the HPV16 integrant in these cells [18].
SiHa cervical SCC cells (which are near triploid [22]) were
shown by Southern blotting using full length HPV16 to be
episome free and to contain approximately 3 integrants
per cell, in keeping with previous reports [16,23]. South-
ern hybridisation using the E6 probe also suggested a viral
load of approximately 3 copies per cell, whereas the E2
probe did not detect a signal. By qPCR SiHa was calcu-
lated to contain 3.4 copies of E6 per diploid genome, indi-
cating a viral load of 5 copies per triploid cell (after
rounding down). By qPCR, SiHa was also calculated to
contain 0.7 copies of E2 per diploid genome, indicating
error at the limits of qPCR performance, as the E2 hinge
region is not retained in SiHa [15]. The mean E2/E6 ratio
for SiHa was 0.20, with a range of 0.11 to 0.24.
CaSki cervical SCC cells (which are near tetraploid [22])
were shown by Southern blotting using full length HPV16
probe to be episome free and to contain more than 1,000
integrated copies per cell. By qPCR, CaSki was determined
to carry approximately 2,272 E2 copies, and 869 E6 copies
per diploid genome, the latter equating to a viral load of
1,738 E6 copies per tetraploid cell. The mean E2/E6 ratio
for CaSki was 2.61, with a range of 1.37 to 3.46. Southern
hybridisation using the E2 and E6 probes confirmed the
presence of greater copy numbers of E2 than E6 in CaSki
(Figure 3; compare panels B and C), and 1-dimensional
analysis of the autoradiogram gave an E2/E6 ratio of
approximately 2.
The data from the detailed cell line analysis confirms that
errors in SYBR green qPCR-based HPV16 gene quantifica-
tion should be allowed for, especially at low copy
number. Nevertheless, the viral loads determined from
mean E6 copy numbers were reasonably close to the val-
ues shown by Southern blotting and can be considered to
provide a useable indication of actual loads. The E2/E6
ratios also showed considerable variation, which again
was greatest at low copy number. Moreover, when taking
mean ratio values, our data shows that while integrated
HPV16 in the absence of episomes may produce a low E2/
E6 ratio, the presence of a high E2/E6 ratio, even one
greater than 1.0, does not exclude the presence of inte-
grated HPV16 only.
Estimation of viral load and physical state of HPV16 in 
cervical clinical samples
The SYBR green qPCR method was also used to assess
copy number of HPV16 genes in frozen tissue samples
from fourteen HPV16-positive cervical SCCs (Table 5).
Viral loads were determined as E6 copy number per dip-
loid genome, and could broadly be classified into three
levels; low (up to 50 viral copies per diploid genome);
medium (approximately 300 to 700 viral copies per dip-
loid genome); and high (above 2000 viral copies per dip-
loid genome, seen in one sample only).
E2/E6 ratios were also determined for the SCCs. In three
samples (n55, G9, G31), E2/E6 ratios were 0.06 or less,
indicative of fully integrated HPV16 only (Table 5, '*'
marked samples). In a fourth sample (G1) the ratio was
0.21, while in ten other samples it ranged from 0.38–1.55
(Table 5, right hand column). Such values have previously
been considered to indicate the presence of episomes,
with or without coexistence of integrants [5,11,24]. How-
ever, in view of our findings with cell lines, we concluded
that these values may also represent integrated HPV16
only and that, consequently, no information regarding
HPV16 physical state could be drawn with confidence
from the E2/E6 values for these eleven samples.
Discussion
HPV load and physical status have been claimed to be use-
ful parameters for clinical evaluation of cervical squa-
mous cell neoplasia [7,25-29]. Various PCR
methodologies are described for estimation of HPV load,
type and physical state [8,10,30-35]. Most of these tech-
niques rely on the use of cloned full length HPV16 in
order to produce a calibration curve for absolute quantifi-
cation, with viral loads generally presented in terms of
copies per unit mass of gDNA. However, thorough critical
testing of these methods, using approaches similar to
those in the present study, has been reported only rarely,
and not at all for SYBR green based strategies.
Quantification of E2 and E6 relative to gDNA mass is sub-
ject to sources of potential error, including the need to
quantify gDNA by spectrophotometry. Indeed it appears
to have generated an error in the assessment of viral load
in SiHa, which was determined in one study to be
172,991 copies of E6 in 50 ng of gDNA [13]. 50 ng of
gDNA is equivalent to 4,630 triploid cells, giving a viral
load in SiHa of 37 copies per cell, a substantial overesti-
mate of the copy number demonstrated by Southern blot-
ting. Such error may be reduced by using a calibration
curve generated from a single clone, such as NA6, contain-
ing E2, E6 and HMBS amplicons in a 1:1:1 ratio. The NA6
standard curve enables the number of diploid genomes in
a sample to be determined from the HMBS copy number.
Although we have not performed direct comparisons, this
approach should offer some advantages over alternative
standardisation methods, as it negates the need to deter-
mine each sample concentration accurately, or to haveBMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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knowledge of ploidy, and provides a reference point for
comparison of unrelated specimens and PCR runs.
We undertook rigorous testing of the performance of
SYBR green absolute qPCR in determining HR-HPV gene
copy number. In experiments using virus host DNA mix-
tures we observed substantial run to run variation in PCR
data and identified potential sources of error in copy
number determination. Firstly, we observed that using an
individual calibration curve produced variation in gene
quantification of up to 31%, emphasizing the need to
derive a standard curve from multiple replicate qPCR
runs. Four such runs were used in our study.
Secondly, when we investigated the ability of SYBR green
qPCR to derive gene copy numbers from test gDNA in
which known amounts of HPV16 DNA had been added,
we found moderate variation in quantification of individ-
ual E2 and E6 amplicons. This is consistent with the inher-
ent potential for error in the procedures that we
undertook in the relevant experiments, including estimat-
ing DNA concentration by spectrophotometry and serially
diluting test samples. Estimates of viral load that were
internally normalised to HMBS copy number showed
error rates of 13–53%, a limitation that should be kept in
mind when performing qPCR work.
In contrast to other studies in the literature, we also criti-
cally evaluated the performance of our SYBR green qPCR
method in quantifying HPV16 gene copy number in a
range of cervical keratinocyte cell lines. We observed rea-
sonable agreement between viral loads determined by
qPCR and Southern blotting, with some overestimation of
low viral copy number by qPCR. The SYBR green method
that we used determined an HPV16 copy number in SiHa
of 5 copies per cell, which is an order of magnitude more
accurate than a study that used gDNA levels quantified by
spectrophotometry [13].
Our cell line data therefore suggests that our estimates of
viral load (ranging from 2 to 2,000 copies per diploid
genome) in a set of fourteen HPV16 positive cervical SCC
clinical samples are likely to be broadly accurate, albeit
subject to the errors that we demonstrated using HPV16/
gDNA mixtures. Taken together, our detailed evaluation
supports the use of SYBR green HPV16 qPCR in studies
attempting to correlate viral copy number with clinical
outcome using tissue specimens, at least where the degree
of sampling of abnormal tissue is known.
We observed a wide range of E2/E6 ratios in cell lines and
clinical samples. In integrant only SiHa cells the E2/E6
ratio was substantially greater than 0, at 0.2 (0.11–0.24),
while in integrant only CaSki cells it was 2.61 (1.37–
3.46), as a result of multiple integrants with greater repre-
sentation of E2 than E6. These values (and their ranges)
are attributable to the errors implicit in HPV gene quanti-
fication by qPCR, as well as to the retention of E2
sequences in some integrants. The latter may be full-
length E2, as in CaSki, or alternatively fragments of E2
retaining the hinge region that is amplified by the most
frequently used gene quantification primers (including
those in the present study). While the hinge is the region
of E2 that is most commonly deleted in HPV16 integra-
tion, it may also be retained; as is the case in the integrant
in W12.Ser1p57 [18]. It should be noted that an excess of
E2 copy number over E6 copy number is likely to be rare
in cervical SCCs and only encountered in cells with high
level genomic instability, such as CaSki. On the other
hand, W12.Ser1p57 appears to be more representative of
cells in vivo, with a low copy number of integrated
HPV16. In W12.Ser1p57 we observed a mean E2/E6 ratio
of 0.72, with a range of 0.57 to 3.82.
The E2/E6 ratios in episome-containing W12Ser1p16 cells
ranged from 0.76–1.32 in triplicate assays. Nagao et al
observed E2/E6 ratios of 0.61–1.13 in cervical carcinomas
that were confirmed to contain HPV16 episomes only
[24]. This group also identified cases with mixed integrant
and episome infection in which the E2/E6 ratio was 0.41–
0.55, consistent with their findings from experiments
mixing plasmids containing full length HPV16 DNA and
HPV6 E6 DNA [24]. Our current data suggests that E2/E6
ratios in this range could also reflect integrated HPV16
only and the presence of episomes cannot be assumed in
such cases.
In our opinion, only very low E2/E6 ratios are likely to be
good indicators of the integrant only state. We propose an
E2/E6 ratio of 0.10 or less, as values greater than this are
unlikely to discriminate reliably between integrant only
samples and samples where episomes are present. A pre-
vious study showed that E2/E6 ratios under 0.10 were
only seen where integrated HPV16 DNA was in 10 fold or
greater excess over episomal HPV16 DNA [5]. However
even these findings are rather questionable, as the qPCR
assay used (in which gene copy numbers were referenced
to a fixed mass of gDNA) gave an E2/E6 ratio of 0.25 when
integrated and episomal DNA were present in a 1:1 mix-
ture and 0.56 when episomal DNA was in 10 fold excess.
Moreover, as with most published reports, no absolute
copy number values were reported in the study [5].
E2/E6 ratios less than 0.10 are likely to be encountered
rarely. Indeed, in our study we observed such values in
only three of 14 HPV16 positive cervical SCCs. In the
other cases, we consider that no reliable conclusions
regarding viral state could be drawn from the E2/E6 ratio,
indicating its limited usefulness when applied to clinical
samples and uncharacterized cell lines. Based on theseBMC Biotechnology 2008, 8:57 http://www.biomedcentral.com/1472-6750/8/57
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findings, we suggest that data from previous studies using
the E2/E6 ratio to examine the physical state of HPV16 in
clinical samples may not be accurate, and, in particular
may have overestimated the frequency of mixed integrant
and episomal infections in cervical neoplasia [5,13].
Authors' contributions
IR devised the experiments, prepared the NA6 calibrator
clone, and carried out accuracy tests and assessment of cell
lines by qPCR. GN undertook assessment of clinical sam-
ples by qPCR and NF prepared calibration curves. W12
cell line establishment, propagation and gDNA prepara-
tions were made by MS and MRP. MTH prepared other
cell line gDNA and contributed to the development of the
qPCR method. AT provided statistical input and advised
on qPCR mathematics. IR and NC wrote the manuscript.
This work was funded by MRC and CRUK programme
grants held by NC.
Additional material
Acknowledgements
The authors thank Scott Allen Rauch for permission to employ and distrib-
ute XlXtrFun and Andrew Pope for permission to employ and distribute 
IntersectComplex.
References
1. Morris M, Tortolero-Luna G, Malpica A, Baker VV, Cook E, Johnson
E, Follen Mitchell M: Cervical intraepithelial neoplasia and cer-
vical cancer.  Obstet Gynecol Clin North Am 1996, 23:347-410.
2. Ambros RA, Kurman RJ: Current concepts in the relationship of
human papillomavirus infection to the pathogenesis and
classification of precancerous squamous lesions of the uter-
ine cervix.  Semin Diagn Pathol 1990, 7:158-172.
3. Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink
AP, de Schipper FA, Meijer CJ: High-risk HPV testing in women
with borderline and mild dyskaryosis: long-term follow-up
data and clinical relevance.  J Pathol 2001, 195:300-306.
4. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens
M, Grace M, Huh K: Mechanisms of human papillomavirus-
induced oncogenesis.  J Virol 2004, 78:11451-11460.
5. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM:
Human papillomavirus type 16 integration in cervical carci-
noma in situ and in invasive cervical cancer.  J Clin Microbiol
2006, 44:1755-1762.
6. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK: Viral load, E2
gene disruption status, and lineage of human papillomavirus
type 16 infection in cervical neoplasia.  J Infect Dis 2006,
194:1706-1712.
7. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi
GA, Gallinella G, Costa S, Musiani M, Zerbini M: Viral DNA load,
physical status and E2/E6 ratio as markers to grade HPV16
positive women for high-grade cervical lesions.  Gynecol Oncol
2007, 106:549-557.
8. Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H,
More E, Staudach A, Dietze O, Hauser-Kronberger C: Comparison
of real-time PCR signal-amplified in situ hybridization and
conventional PCR for detection and quantification of human
papillomavirus in archival cervical cancer tissue.  J Clin Micro-
biol 2004, 42:3758-3765.
9. Ho CM, Cheng WF, Chu TY, Chen CA, Chuang MH, Chang SF, Hsieh
CY: Human papillomaviral load changes in low-grade squa-
mous intraepithelial lesions of the uterine cervix.  Br J Cancer
2006, 95:1384-1389.
10. Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV:
Reproducibility of HPV 16 and HPV 18 viral load quantita-
tion using TaqMan real-time PCR assays.  J Virol Methods 2003,
112:23-33.
11. Lefevre J, Hankins C, Pourreaux K, Voyer H, Coutlee F: Real-time
PCR assays using internal controls for quantitation of HPV-
16 and beta-globin DNA in cervicovaginal lavages.  J Virol Meth-
ods 2003, 114:135-144.
12. Lai HC, Peng MY, Nieh S, Yu CP, Chang CC, Lin YW, Sun CA, Chu
TY: Differential viral loads of human papillomavirus 16 and
58 infections in the spectrum of cervical carcinogenesis.  Int J
Gynecol Cancer 2006, 16:730-735.
13. Peitsaro P, Johansson B, Syrjanen S: Integrated human papilloma-
virus type 16 is frequently found in cervical cancer precur-
sors as demonstrated by a novel quantitative real-time PCR
technique.  J Clin Microbiol 2002, 40:886-891.
14. Ho CM, Chien TY, Huang SH, Lee BH, Chang SF: Integrated
human papillomavirus types 52 and 58 are infrequently
found in cervical cancer, and high viral loads predict risk of
cervical cancer.  Gynecol Oncol 2006, 102:54-60.
15. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM:
Structural and transcriptional analysis of human papilloma-
virus type 16 sequences in cervical carcinoma cell lines.  J Virol
1987, 61:962-971.
16. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Pres-
ence and expression of human papillomavirus sequences in
human cervical carcinoma cell lines.  Am J Pathol 1985,
119:361-366.
17. Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA,
Coleman N: Selection of cervical keratinocytes containing
integrated HPV16 associates with episome loss and an
endogenous antiviral response.  Proc Natl Acad Sci U S A 2006,
103:3822-3827.
18. Pett MR, Alazawi WO, Roberts I, Dowen S, Smith DI, Stanley MA,
Coleman N: Acquisition of high-level chromosomal instability
is associated with integration of human papillomavirus type
16 in cervical keratinocytes.  Cancer Res 2004, 64:1359-1368.
19. Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA, Coleman
N: Changes in cervical keratinocyte gene expression associ-
ated with integration of human papillomavirus 16.  Cancer Res
2002, 62:6959-6965.
20. Sterling J, Stanley M, Gatward G, Minson T: Production of human
papillomavirus type 16 virions in a keratinocyte cell line.  J
Virol 1990, 64:6305-6307.
21. Ng G, Winder D, Muralidhar B, Gooding E, Roberts I, Pett M,
Mukherjee G, Huang J, Coleman N: Gain and overexpression of
the oncostatin M receptor occur frequently in cervical squa-
Additional file 1
Crossing point values used in critical evaluation of HPV16 gene copy 
number quantification by SYBR green PCR. The Microsoft Excel work-
book of Additional file 1 contains four worksheets. 1: NA6 Standard 
Curves. The crossing point values used in generation of external calibra-
tion curves for absolute quantification of viral E2, viral E6 and host 
HMBS genes are presented. For each gene, four runs of a seven point NA6 
titration series were conducted in triplicate. 2: Accuracy Test. The cross-
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